Literature DB >> 20227928

Diagnosis of lactose intolerance and the "nocebo" effect: the role of negative expectations.

Piero Vernia1, Mauro Di Camillo, Tiziana Foglietta, Veronica E Avallone, Aurora De Carolis.   

Abstract

BACKGROUND: Diagnosis of lactose intolerance is based on a "positive" H(2) breath test associated with abdominal symptoms. The present study established to what extent the occurrence of symptoms during a "negative" H(2) breath test may result from a "nocebo effect" instead of lack of sensitivity of the procedure.
METHODS: Between 2005 and 2007, 636 outpatients performed a standard 4-h 25g lactose tolerance test. The test was positive in 254, negative in 325, and 57 patients were H(2) "non-producers". Twenty-seven patients reporting symptoms despite a negative H(2) breath test underwent a "sham" breath test following ingestion of 1g of glucose. Fifty-four patients presenting with documented lactose intolerance were used as controls.
RESULTS: Twelve out of 27 patients (44.4%), and unexpectedly also 14 (25.9%) controls presented abdominal symptoms during the sham test. The difference between the two groups was not significant (P<0.15) OR 2.28; C.I. 0.77-6.78.
CONCLUSION: In most instances, symptoms reported by patients during a negative lactose H(2)BT cannot be attributed to a false-negative test. Instead, a non-organic component, resulting from negative expectations ("nocebo effect") is likely implicated. Moreover, also in patients diagnosed as lactose intolerant, the need for restricting the primary source of dietary calcium should be critically reconsidered. Copyright (c) 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227928     DOI: 10.1016/j.dld.2010.02.005

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  14 in total

Review 1.  Nocebo in headaches: implications for clinical practice and trial design.

Authors:  Dimos D Mitsikostas
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 2.  Nocebo phenomena in medicine: their relevance in everyday clinical practice.

Authors:  Winfried Häuser; Ernil Hansen; Paul Enck
Journal:  Dtsch Arztebl Int       Date:  2012-06-29       Impact factor: 5.594

3.  Lactose intolerance: diagnosis, genetic, and clinical factors.

Authors:  Rejane Mattar; Daniel Ferraz de Campos Mazo; Flair José Carrilho
Journal:  Clin Exp Gastroenterol       Date:  2012-07-05

4.  Additional Value of CH₄ Measurement in a Combined (13)C/H₂ Lactose Malabsorption Breath Test: A Retrospective Analysis.

Authors:  Els Houben; Vicky De Preter; Jaak Billen; Marc Van Ranst; Kristin Verbeke
Journal:  Nutrients       Date:  2015-09-07       Impact factor: 5.717

5.  Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Authors:  Lars Erik Kristensen; Rieke Alten; Luis Puig; Sandra Philipp; Tore K Kvien; Maria Antonia Mangues; Frank van den Hoogen; Karel Pavelka; Arnold G Vulto
Journal:  BioDrugs       Date:  2018-10       Impact factor: 5.807

Review 6.  The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases.

Authors:  Paul Enck; Sibylle Klosterhalfen
Journal:  Front Pharmacol       Date:  2021-03-31       Impact factor: 5.810

7.  Blinded Oral Challenges with Lactose and Placebo Accurately Diagnose Lactose Intolerance: A Real-Life Study.

Authors:  Alba Rocco; Debora Compare; Costantino Sgamato; Alberto Martino; Luca De Simone; Pietro Coccoli; Maria Laura Melone; Gerardo Nardone
Journal:  Nutrients       Date:  2021-05-13       Impact factor: 5.717

Review 8.  Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases.

Authors:  Andrew Szilagyi
Journal:  Nutrients       Date:  2015-08-13       Impact factor: 5.717

9.  Significance of hydrogen breath tests in children with suspected carbohydrate malabsorption.

Authors:  Jan Däbritz; Michael Mühlbauer; Dirk Domagk; Nicole Voos; Geraldine Henneböhl; Maria L Siemer; Dirk Foell
Journal:  BMC Pediatr       Date:  2014-02-27       Impact factor: 2.125

10.  The nocebo effect of drugs.

Authors:  Sara Planès; Céline Villier; Michel Mallaret
Journal:  Pharmacol Res Perspect       Date:  2016-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.